Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up

• Published in: Diagnostic pathology 2012-06, Vol.7 (1), p.63-63, Article 63
• Main Authors: González-Yebra, Beatriz, Peralta, Raúl, González, Ana Lilia, Ayala-Garcia, Marco Antonio, de Zarate, María E Medrano Ortiz, Salcedo, Mauricio
• Format: Article
• Language: English
• Subjects: Aged; Analysis; Calcitonin; Cancer; Carcinoma; Carcinoma, Neuroendocrine; Case Report; Case studies; Chromosomal alterations; Chromosomes; Chromosomes, Human, Pair 16 - genetics; Chromosomes, Human, Pair 18 - genetics; Chromosomes, Human, Pair 6 - genetics; Comparative Genomic Hybridization; Consent; Cytogenetics; Deoxyribonucleic acid; Diagnosis; DNA; DNA methylation; Female; Follow-Up Studies; Genes; Genetic aspects; Humans; Lymphatic Metastasis - genetics; M918T RET mutation; Medical research; Medicine, Experimental; Metastasis; Mutation; Physiological aspects; Prognosis; Proto-Oncogene Proteins c-ret - genetics; Risk factors; Sporadic MTC; Surgery; Thyroid cancer; Thyroid diseases; Thyroid Neoplasms - genetics; Thyroid Neoplasms - pathology; Tumors
• ISSN: 1746-1596; 1746-1596
• DOI: 10.1186/1746-1596-7-63

Association between DNA alterations and clinical parameters as recurrence, survival or prognosis has been found in a variety of tumors. A clear association between Medullary Thyroid Carcinoma (MTC) and RET oncogene mutation has been accepted. Specifically M918T RET mutation represents the main genetic event in most cases of sporadic MTC (SMTC) and limited chromosomal alterations analyses have been performed. In the present work, a comparative genomic hybridization (CGH) study was performed using DNA from a primary tumor in a M918T RET mutation-positive SMTC patient and from its lymph node metastasis to investigate additional genetic alterations. We studied a patient with 15 years of follow-up and persistence of disease, confirmed by periodical elevated serum calcitonin (CT) levels. Only 3 chromosomal imbalances were identified in the primary tumor, gain of 18p, and loss of 6p and 16p region, whereas 25 chromosomal imbalances were identified in the metastasis (9 gains and 16 losses). The chromosomal changes 6p-, 16p-, 18p + could determine in part the oncogenic phenotype in the primary M918T RET positive tumor and probably related to persistence of high serum CT levels in this patient. The additional chromosomal changes observed could be related to the metastasis phenotype. We suggest that some genes mapped at 6p, 16p and 18p chromosomal regions, could act as genes associated to cancer and could be related to persistent SMTC and good prognosis. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1720753793691097.